Weight-lowering specialist: pharmaceutical company Lilly buys three vaccine developers for billions
WirtschaftsWoche·2d·Media
The US pharmaceutical company is investing up to $3.8 billion in three vaccine developers. What the Group is planning to do with the new products.
TickersUSChannelscurrencies, semiconductors, stocksCountriesgermany, europe, ukCategoriescurrencies
Open original source ↗Published
5/26/2026, 2:20:28 PM
Fetched
5/26/2026, 4:07:05 PM
Confidence
60 / 100
Relevance
37 / 100
Trust
media · 60/100
Language
de